Healthcare Burden of Rare Diseases: A Population-Based Study in Tuscany (Italy).
data linkage
disease registry
hospitalisation
length of stay
rare diseases
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
21 06 2022
21 06 2022
Historique:
received:
29
04
2022
revised:
14
06
2022
accepted:
17
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
14
7
2022
Statut:
epublish
Résumé
Patients with rare diseases (RDs) need tailored, continuous, and multidisciplinary hospital care. This retrospective cohort study aimed to analyse the healthcare burden of RD patients using a multi-database approach, by linking the data of the Rare Diseases Registry of Tuscany with the regional hospital discharge database. The study population included 21,354 patients diagnosed with a RD between 1 January 2000 and 31 December 2017. The healthcare burden was evaluated for all the RDs during 2009-2018 period. The hospitalisation rate (per 1000) decreased over the years, ranging from 606.9 in 2009 (95% CI: 589.2-625.0) to 443.0 in 2018 (95% CI: 433.2-453.0). A decrease in the average length of stay (LOS) was observed in the earlier years, followed by an increase up to a steady trend (8.3 days in 2018). The patients with RDs of metabolism and the genitourinary system showed the highest hospitalisation rate (903.3 and 644.0 per 1000, respectively). The patients with rare immune system disorders and diseases of the skin and subcutaneous tissue showed the highest LOS (9.7 and 9.5 days, respectively). The methodological approach presented in this population-based study makes it possible to estimate the healthcare burden of RDs, which is crucial in the decision-making and planning aimed at improving patient care.
Identifiants
pubmed: 35805212
pii: ijerph19137553
doi: 10.3390/ijerph19137553
pmc: PMC9265803
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Public Health (Oxf). 2019 Mar 1;41(1):46-54
pubmed: 29294017
Orphanet J Rare Dis. 2021 Feb 27;16(1):105
pubmed: 33639989
J Inherit Metab Dis. 2002 Nov;25(7):531-46
pubmed: 12638937
Public Health Genomics. 2017;20(4):229-234
pubmed: 29045944
Adv Exp Med Biol. 2010;686:3-14
pubmed: 20824436
Health Policy. 2015 Jul;119(7):964-79
pubmed: 25661982
J Clin Pathol. 2014 Dec;67(12):1099-103
pubmed: 25271213
Prev Chronic Dis. 2016 Jan 14;13:E05
pubmed: 26766846
Arch Pediatr Adolesc Med. 1997 Nov;151(11):1096-103
pubmed: 9369870
Orphanet J Rare Dis. 2019 Jul 1;14(1):160
pubmed: 31262329
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
Neurology. 2012 Jul 10;79(2):123-6
pubmed: 22675082
Isr Med Assoc J. 2016 Jun;18(6):359-63
pubmed: 27468531
Genet Med. 2021 Nov;23(11):2194-2201
pubmed: 34183788
Orphanet J Rare Dis. 2021 Jun 8;16(1):262
pubmed: 34103049
Lung. 2017 Aug;195(4):411-418
pubmed: 28456873
Clin Transl Sci. 2018 Jan;11(1):11-20
pubmed: 28796411
Am J Med Genet A. 2019 Jun;179(6):885-892
pubmed: 30883013
Nat Rev Genet. 2018 May;19(5):253-268
pubmed: 29398702
Genet Med. 2017 May;19(5):546-552
pubmed: 27657686
Cureus. 2021 Mar 29;13(3):e14177
pubmed: 33936888
JAMA. 2015 May 12;313(18):1841-52
pubmed: 25965233
Orphanet J Rare Dis. 2021 Jun 14;16(1):275
pubmed: 34127030
Orphanet J Rare Dis. 2014 Mar 19;9:37
pubmed: 24646171
Gastroenterol Rep (Oxf). 2021 Jan 15;9(1):38-48
pubmed: 33747525
Neurol Ther. 2013 Mar 22;2(1-2):1-12
pubmed: 26000212
Orphanet J Rare Dis. 2021 Feb 17;16(1):90
pubmed: 33596949
Lancet. 2008 Jun 14;371(9629):2039-41
pubmed: 18555915
Med Care. 1980 Feb;18(2 Suppl):iii, 1-53
pubmed: 7188781
Orphanet J Rare Dis. 2017 Apr 11;12(1):68
pubmed: 28399928
Value Health. 2019 Sep;22(9):1003-1011
pubmed: 31511176
Orphanet J Rare Dis. 2021 Aug 3;16(1):336
pubmed: 34344397
Orphanet J Rare Dis. 2021 Mar 9;16(1):121
pubmed: 33750434
Birth Defects Res A Clin Mol Teratol. 2016 Mar;106(3):155-63
pubmed: 26690723
Orphanet J Rare Dis. 2018 Aug 28;13(1):147
pubmed: 30153866